Novan, Inc. filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of certain assets on September 1, 2023. As a result of the auction conducted on August 31, 2023, and Ligand Pharmaceuticals has been selected as the winning bidder for the sale of debtor?s certain assets. The debtor?s assets include R&D Assets and certain Commercial Assets.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.88% | -99.88% | -99.80% |
Jan. 17 | First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc. | CI |
2023 | Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+190.94% | 6.96B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 830M | |
+1.72% | 664M | |
+5.92% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- NOVN Stock
- News NVN Liquidation, Inc.
- Notice of selection of Successful Bidder Filed by Novan, Inc.